Paragon Therapeutics, Inc.
Neta Batscha is the VP of Corporate Strategy and Operations at Paragon Therapeutics, Inc. since September 2021, with prior experience as VP of Biotech Investment Underwriting at The Beneficient Company Group, L.P. from May 2020 to September 2021. Previously, Neta worked for RA Capital Management, L.P. as a Venture Associate, where responsibilities included establishing the firm's Texas presence and leading due diligence for life science investments, as well as serving as an Equity Analyst focusing on biotechnology companies. Neta's early career also involved various research roles, including Board Observer positions at Lyra Therapeutics, Satsuma Pharmaceuticals, and Sojournix. Neta's academic credentials include a BS in Biology from the Massachusetts Institute of Technology, complemented by research experiences in multiple prestigious organizations.
This person is not in any teams
This person is not in any offices
Paragon Therapeutics, Inc.
Paragon Therapeutics, Inc. is a biotechnology company dedicated to discovering and developing best-in-class biologics for patients with high unmet needs. Our collaborative team of innovators has deep expertise in biologics engineering and development and a passion to tackle some of the toughest disease areas and improve quality of life for patients. If you’re eager to help shape the next generation of biologic treatments, join us! Check out our open positions and learn more at paragontherapeutics.com.